Immunoengineering | AIChE

Other Sites & Tools

Technical Groups

Immunoengineering

Immunoengineering

Presentations

1:00 PM
Vignettes on Engineering Targeted, Immunomodulatory Therapies
1:30 PM
Inhibition of Cancer Immune Suppression with a First-in-Class Engineered Therapeutic Enzyme
1:45 PM
Engineering Robust T Cells for Cancer Immunotherapy
2:00 PM
Quantitative In Vivo & Ex Vivo Multimodality Cell Imaging of Antigen-Specific T-Cells in Murine Metastatic Ovarian Cancer
2:15 PM
Single-Cell Profiling Demonstrates That Migratory T Cells Demonstrate Superior Persistence and Enhanced Tumor Control
2:30 PM
Engineering Nanotechnologies for Immuno-Oncology: "Smart" Nanoparticles for Immunotherapeutic Targeting of the Sting Pathway
2:45 PM
Direct Selection of Synthetic Binding Proteins That Recognize Post-Translationally Modified Proteins in Living Cells
3:00 PM
Utilizing Oxygen-Inhibited Photopolymerization to Control Size of Multimodal PEGDA Hydrogel Nanoparticles for Cancer Therapeutics